Search
for

    GlossaryIonotropic Receptor (Ligand-Gated Ion Channel)

    allows ions to pass through the cell membrane upon activation

    An ionotropic receptor, also known as a ligand-gated ion channel, is a type of receptor that allows ions to pass through the cell membrane in response to the binding of a chemical messenger, such as a neurotransmitter. When the neurotransmitter binds to the receptor, it causes the channel to open, allowing specific ions like sodium, potassium, or calcium to flow into or out of the cell, which can trigger various cellular responses.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 1000+ results

    Community Join

    5 / 14 results

      community Ligand Chem cease trading Pyrilutamide

      in Product  14 upvotes 1 year ago
      Pyrilutamide, a possible hair loss treatment, ceasing to be traded due to patent laws; and the hope that this indicates it may be a legitimate treatment.

      community Dropping RU , not responding..

      in Treatment  6 upvotes 5 months ago
      The user has been using RU58841 for 6 months without noticeable results and is considering dropping it while continuing oral minoxidil, daily dutasteride, and topical minoxidil. Another user suggests visiting a dermatologist to check for other conditions.

      community Bile Acid-Mediated DHT Dysregulation Hypothesis

      in Research/Science  13 upvotes 2 weeks ago
      Elevated bile acids can inhibit the enzyme AKR1C2, leading to increased DHT levels, which may accelerate hair loss in those predisposed to androgenetic alopecia. Treatments mentioned include topical minoxidil and finasteride.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.